Sotera Health (SHC) Stock Forecast & Price Target

$16.76

+0.17 (+1.02%)

(As of 09/27/2024 ET)

Sotera Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 6 Analyst Ratings

Sell
0

Hold
2

Buy
4

Based on 6 Wall Street analysts who have issued ratings for Sotera Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 2 have given a hold rating, and 4 have given a buy rating for SHC.

Consensus Price Target

$15.70
-6.32% Downside

According to the 6 analysts' twelve-month price targets for Sotera Health, the average price target is $15.70. The highest price target for SHC is $17.00, while the lowest price target for SHC is $13.00. The average price target represents a forecasted downside of -6.32% from the current price of $16.76.

SHC Analyst Ratings Over Time

Type	Current Forecast 9/29/23 to 9/28/24	1 Month Ago 8/30/23 to 8/29/24	3 Months Ago 7/1/23 to 6/30/24	1 Year Ago 9/29/22 to 9/29/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$15.70	$15.70	$16.92	$17.86
Forecasted Upside	-6.32% Downside	1.23% Upside	42.52% Upside	19.21% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Jovine Was Right in 2008—Will You Listen This Time? (Ad)

The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.

Take these 4 steps today to protect your retirement NOW

SHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Sotera Health Stock vs. The Competition

Type	Sotera Health	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.78	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	-6.32% Downside	818.62% Upside	6.14% Upside
News Sentiment Rating	Positive News See Recent SHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/6/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$17.00 ➝ $17.00	+16.76%
8/6/2024	Barclays 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$14.00 ➝ $17.00	+16.76%
5/21/2024	Piper Sandler 2 of 5 stars	J. Bednar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$13.00	+17.22%
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$18.00 ➝ $16.00	+40.60%
3/25/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$15.00 ➝ $15.50	+37.17%
2/6/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sector Weight
Jovine Was Right in 2008—Will You Listen This Time? (Ad) The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future. Take these 4 steps today to protect your retirement NOW
1/23/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underweight ➝ Neutral	$6.00 ➝ $18.00	+6.38%
1/10/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Peer Perform ➝ Outperform	$25.00	+44.93%
11/23/2022	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$9.00 ➝ $8.00	-3.03%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:03 PM ET.

SHC Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Sotera Health is $15.70, with a high forecast of $17.00 and a low forecast of $13.00.
: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SHC shares.
: According to analysts, Sotera Health's stock has a predicted downside of -6.32% based on their 12-month stock forecasts.
: Sotera Health has been rated by research analysts at Barclays, and Royal Bank of Canada in the past 90 days.
: Analysts like Sotera Health less than other "medical" companies. The consensus rating score for Sotera Health is 2.67 while the average consensus rating score for "medical" companies is 2.78. Learn more on how SHC compares to other companies.